| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5899758 | Diabetes Research and Clinical Practice | 2014 | 9 Pages |
Abstract
The Australian TLC Diabetes intervention was a low-cost investment for individuals with established diabetes and may result in medication cost-savings to the health system. Although QALYs were similar between groups, other benefits arising from the intervention should also be considered when determining the overall value of this strategy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
L.G. Gordon, D. Bird, B. Oldenburg, R.H. Friedman, A.W. Russell, P.A. Scuffham,